Cbset Funding: How Much Did They Raise & Key Investors

How Much Did Cbset Raise?
Funding & Key Investors

Cbset, a prominent biomedical research institute based in Lexington, Massachusetts, has successfully secured significant capital to bolster its preclinical service offerings. The organization has reached a cumulative financial milestone of $2.2M, with the most recent strategic investment totaling $1.2M. This influx of financing underscores the market confidence in the institute's ability to bridge the gap between early-stage scientific discovery and regulatory approval for its diverse portfolio of global sponsors.

The capital injection arrives at a pivotal moment for the firm, as it continues to scale its GLP-compliant operations and expand its specialized research infrastructure. By maintaining a robust balance sheet, Cbset is well-positioned to navigate the complexities of the medical device and pharmaceutical sectors, ensuring that its collaborative research model remains at the forefront of biomedical innovation.

What is Cbset?

Cbset

Business Services

Research & Development

Cbset operates as a not-for-profit biomedical research entity, providing a comprehensive suite of preclinical services within a 40,000-square-foot, AAALAC-accredited facility. The company distinguishes itself through an integrated paradigm that synthesizes in vivo and in vitro studies with advanced computational and 3D modeling. By offering specialized capabilities such as catheterization, imaging labs, and complex histopathology, Cbset serves as a critical partner for academic institutions and commercial enterprises aiming to achieve rigorous scientific and regulatory benchmarks. Its commitment to high-quality, GLP-compliant research makes it a cornerstone of the Lexington biotech ecosystem.

How much funding has Cbset raised?

Cbset has raised a total of $2.2M across 2 funding rounds:

2020

Debt

$1M

2021

Debt

$1.2M

Debt (2020): $1M with participation from PPP

Debt (2021): $1.2M led by PPP

Key Investors in Cbset

PPP

Public-Private Partnership

What's next for Cbset?

Looking ahead, Cbset is poised to leverage its recent capital to further enhance its technical acumen and operational capacity. The strategic focus will likely remain on deepening its collaborative projects within the medical device and pharmaceutical communities, where the demand for high-fidelity preclinical data is accelerating. As the regulatory landscape for new medical technologies becomes increasingly stringent, Cbset's ability to provide integrated, high-quality research services will be a key driver of its long-term growth. The institute is expected to continue investing in cutting-edge technologies and expanding its expert team to maintain its competitive edge in the global biomedical research market.

See full Cbset company page

See More Financial Insights